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Abstract Cerebral ischemia stimulates endogenous neu-
rogenesis. However, the functional relevance of this
phenomenon remains unclear because of poor survival and
low neuronal differentiation rates of newborn cells. There-
fore, further studies on mechanisms regulating neurogenesis
under ischemic conditions are required, among which eph-
rin-ligands and ephrin-receptors (Eph) are an interesting
target. Although Eph/ephrin proteins like ephrin-B3 are
known to negatively regulate neurogenesis under physio-
logical conditions, their role in cerebral ischemia is largely
unknown. We therefore studied neurogenesis, brain injury
and functional outcome in ephrin-B3
-/- (knockout) and
ephrin-B3
?/? (wild-type) mice submitted to cerebral
ischemia. Induction of stroke resulted in enhanced cell
proliferation and neuronal differentiation around the
lesion site ofephrin-B3
-/-compared to ephrin-B3
?/?mice.
However, prominent post-ischemic neurogenesis in ephrin-
B3
-/- mice was accompanied by signiﬁcantly increased
ischemic injury and motor coordination deﬁcits that per-
sisted up to 4 weeks. Ischemic injury in ephrin-B3
-/- mice
was associated with a caspase-3-dependent activation of the
signal transducer and activator of transcription 1 (STAT1).
Whereas inhibition of caspase-3 had no effect on brain
injury in ephrin-B3
?/? animals, infarct size in ephrin-B3
-/-
mice was stronglyreduced, suggesting thataggravated brain
injuryintheseanimalsmightinvolve acaspase-3-dependent
activation of STAT1. In conclusion, post-ischemic neuro-
genesis in ephrin-B3
-/- mice is strongly enhanced, but fails
to contribute to functional recovery because of caspase-3-
mediated aggravation of ischemic injury in these animals.
Our results suggest that ephrin-B3 might be an interesting
target forovercoming someofthe limitations offurther cell-
based therapies in stroke.
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Introduction
Endogenous neurogenesis persists within distinct areas of
the adult mammalian brain such as the subventricular zone
(SVZ) [19, 36, 37]. Within this germinal niche, astrocyte-
like neural stem cells give rise via rapidly dividing cells to
neuroblasts, which migrate along the rostral migratory
stream towards the olfactory bulb, where they differentiate
into mature neurons [1, 13, 14].
Various physiological and pathological stimuli enhance
neurogenesis, among which cerebral ischemia is known to
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neural precursor cells (NPCs) [2, 23, 27, 45]. Although
increased neurogenesis under ischemic conditions could
contribute to regeneration and restoration, the functional
relevance of this phenomenon remains unclear because of
poor survival and low neuronal differentiation rates of
newborn cells [9, 47]. In order to develop successful neu-
roregenerative concepts, further knowledge of mechanisms
regulating adult neurogenesis under ischemic conditions is
urgently needed.
In this context, membrane-bound ephrin proteins inter-
acting via their corresponding ephrin receptors (Eph-
receptor) in a bidirectional way [15] have gained increasing
attention as signaling molecules associated with neurogen-
esis. These proteins have diverse roles during prenatal
development of the brain with special emphasis on axonal
guidance,cell–cell-adhesionandsynapticplasticity[29,43].
In the adult mammalian brain, ephrin-B2 and ephrin-B3
blockade successfully increased both proliferation and
migration of SVZ-derived NPCs under physiological con-
ditions[8,32].Sofar,onlyonestudyhasanalyzedtheroleof
ephrins in the ischemic brain, reporting an increase in pro-
liferationandneuronaldifferentiationofSVZ-derivedNPCs
after competitive inhibition of Eph-B2 [44]. In the current
study, we show that endogenous neurogenesis is increased
after transient focal cerebral ischemia in ephrin-B3 knock-
out mice without contributing to functional neurological
recovery. On the contrary, brain injury in these animals is
highly enhanced, involving a caspase-3-associated activa-
tion of the signal transducer and activator of transcription 1
(STAT1). We propose that aggravated ischemic brain injury
in ephrin-B3 knockout animals is associated with a caspase-
3-dependent phosphorylation of STAT1.
Materials and methods
Experimental groups
Experimental procedures were performed according to the
European Institutes of Health guidelines for the care and
use of laboratory animals and approved by local authori-
ties. Animals were housed under circadian conditions and
had free access to food and water. The ephrin-B3 null mice
used in the study were kindly provided by Nicholas
W. Gale (Regeneron Pharmaceuticals Inc., Tarrytown, NY)
and generated as described previously [25].
For all experiments, adult male ephrin-B3 knockout
(ephrin-B3
–/–) and wild-type mice (ephrin-B3
?/?) with an
age of 11–14 weeks weighing 25–28 g were used. The
total number of animals used was 204. Mice were killed on
day 4, 14 and 28 after induction of stroke. Animals used for
infarct analysis on day 28 (8 animals each) were also used
for behavioral tests. Remaining experimental groups
(4- and 14-day survival) consisted of seven animals each.
For Western blot, caspase-3 analysis and vessel staining
four animals per condition were used. Survival rate was
100% for all experimental groups except for ephrin-B3
-/-
mice that survived for 28 days, 88.9% for animals used for
TTC staining or immunohistochemistry and 80% for
animals used for pump implantation experiments. Post-
ischemic cell proliferation was analyzed using intraperi-
toneal (i.p.) injection of 5-bromo-2-deoxyuridine (BrdU;
Sigma, Germany) on days 0–3 (4-day survival), days 8–13
(14-day survival) or days 8–18 (28-day survival) with a
daily dose of 50 mg/kg bodyweight.
Preparation and cultivation of SVZ-derived neural
precursor cells
Preparation and subsequent cultivation of NPCs was done
according to a modiﬁed protocol from Rietze and Reynolds
[33]. NPCs were isolated from the SVZ of 6–8-week-old
ephrin-B3
-/- and wild-type mice. The SVZ was
micro-dissected under stereomicroscopic control (Zeiss,
Germany) and minced into small pieces, and then
mechanically triturated and dissociated to single cell sus-
pension. Cells were cultured in serum-free basic medium
DMEM-F12 (PAA, Austria) supplemented with epidermal
growth factor (EGF, 2 lg/ml), basic ﬁbroblast growth
factor (bFGF, 2 lg/ml) and penicillin-streptomycin (Invit-
rogen, Germany). Cells were incubated with 5% CO2 at
37C. The growth factors were added every 2–3 days, and
the cells were passaged by accutase digestion and then
re-suspended in pre-warmed conditioned media. Neuro-
sphere passage was done every 7–10 days, and the cells
used for experiments were harvested after passage 2–3.
Quantitative neurosphere analysis
and proliferation assay
For analysis of neurosphere numbers and neurosphere
proliferation, 10,000 NPCs were plated in six-well plates
and cultured for 7 days followed by a quantitative anal-
ysis of the number of primary neurospheres. The
neurospheres were collected with a pipette and transferred
to 24-well plates with coverslips coated with 1 mg/ml
poly-D-lysine (Sigma, Germany) and 5 lg/ml laminin
(Invitrogen, Germany) for immunostaining. The neuro-
spheres were ﬁxed with 4% paraformaldehyde (PFA) for
1 h at 4C, washed in PBS, blocked for 1 h in blocking
solution [0.2% TritonX-100 and 3% bovine serum albu-
min (BSA) in PBS] and incubated overnight with rabbit
anti-phosho-histone-H3 antibody (1:50; Cell Signaling,
USA) at 4C. The neurospheres were then washed and
stained with an anti-rabbit Cy3-conjugated secondary
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detection of the cell nuclei sections were stained with
DAPI (1:20,000; Roth, Germany). The images were
acquired using a confocal microscope (Leica TCS SP2)
equipped with a 209 objective, and quantitative mea-
surements were performed using MetaMorph software
(Molecular Devices, UK).
Neurosphere differentiation assay
For assessment of more subtle differences in cell differ-
entiation, primary neurospheres that had been cultured for
7 days (see above) and neurospheres from passage 3 were
gently triturated and plated on 24-well plates (40 cells/ll)
containing coverslips coated with 1 mg/ml poly-D-lysine
(Sigma, Germany) according to modiﬁed protocols [5, 7].
Plating medium consisted of DMEM/F12 medium sup-
plemented with 2% B27 (Invitrogen, Germany), 1% fetal
bovine serum (FBS) and penicillin-streptomycin to allow
differentiation of cells. For Western blot analysis, cells
were lysed (50 mM Tris at pH 8.0, 150 mM NaCl and
Triton 1%) on day 7 after plating. Lysates were centri-
fuged and supernatants were used for SDS-PAGE. Equal
amounts of protein (75 lg) were diluted in 69 sample
buffer, boiled and loaded onto 10% polyacrylamide gels.
Proteins were transferred onto PVDF membranes, which
then were immersed in blocking solution [5% milk in
TBS-T (0.1% Tween 20 ? TBS); 1 h at RT] and incu-
bated with primary antibodies (solved in TBS-T with 1%
milk; 18 h at 4C). The following primary antibodies
were used: rabbit polyclonal anti-nestin (1:2,000), rabbit
polyclonal anti-glial ﬁbrillary acidic protein (GFAP;
1:10,000), rabbit polyclonal anti-20,30-cyclic nucleotide
30-phosphodiesterase (CNPase; 1 lg/ml) and anti-beta
tubulin III (1 lg/ml; all obtained from Abcam, UK).
Subsequently, membranes were incubated with a peroxi-
dase-coupled, goat anti-rabbit secondary antibody
(1:2,000; Abcam, UK), washed several times, immersed in
ECL solution and exposed to ECL-Hyperﬁlm (Amersham,
Germany).
Oxygen-glucose-deprivation (OGD) test
NPCs from both ephrin-B3
?/? and ephrin-B3
-/- mice
were passaged, and 1,00,000 cells were used for each
condition. Before beginning OGD, cell culture medium
was substituted by a crystalloid solution that does not
contain any glucose (‘‘Thomajodin’’ plus 1 mM mannitol;
DeltaPharm, Germany), and the cells were incubated in a
hypoxic chamber (1% O2,5 %C O 2 and 94% N2) for
45 min and re-incubated in normal glucose-containing cell
culture medium for 24 h. The number of dead cells was
counted using a LIVE/DEAD-Viability/Cytotoxicity-Assay
kit (Lonza, Switzerland). SVZ-derived NPCs from both
ephrin-B3
?/? and ephrin-B3
-/- mice that were incubated
for 24 h under standard cell culture conditions served as
negative controls.
Induction of focal cerebral ischemia
Animals were anesthetized (0.8–1.5% isoﬂuran, 30% O2,
remainder N2O), and rectal temperature was maintained at
36.5–37.0C employing a feedback-controlled heating
system. For assessment of blood ﬂow changes, laser
Doppler ﬂow (LDF) was recorded during all experiments
using a ﬂexible ﬁberoptic probe (Perimed, Sweden), which
was attached to the skull overlying the core region of the
middle cerebral artery (MCA) territory (2 mm posterior,
6 mm lateral from bregma). Cerebral ischemia was induced
by transient occlusion of the MCA using the intraluminal
ﬁlament technique as described previously [12]. Brieﬂy,
following a midline neck incision, the left common and
external carotid artery were isolated and ligated. After
placing a microvascular clip (Aesculap, Germany) on the
internal carotid artery, a 7–0 silicon coated nylon monoﬁl-
ament (180 lm tip diameter; Doccol, USA) was introduced
through an incision into the distal part of the common
carotid artery and, after removing the clip, advanced 9 mm
distal from the carotid bifurcation for MCA occlusion. To
achieve transient ischemia, the monoﬁlament was removed
after 30 min (or 20 min in some ephrin-B3
-/- mice to
achieve similar infarct sizes). LDF recordings continued for
15 min after thread removal to monitor appropriate
reperfusion.
Intraventricular pump implantation
Ephrin-B3-Fc ligands (R&D Systems, Germany; 160 lg/ml
solved in PBS) were pre-clustered for 2 h at room temper-
ature (RT) (anti-human-Fc ratio 5:1; Jackson Research
Laboratories, UK) and applied for intraventricular infusion
using a modiﬁed protocol from Ricard et al. [32]. Ephrin-
B3
-/- mice were anesthetized (see above) 1 day before
induction of stroke, and cannulae (Brain Infusion Kit; Alzet,
USA), which were linked to mini osmotic pumps (volume
200 ll, rate 0.25 ll/h; model Alzet 2004) ﬁlled with Eph-
rin-B3-Fc ligands, were implanted into the left lateral
ventricle through a burr hole [31]. Clustered Fc fragments
were used as controls. Infusion was performed over a
28-day period, and the animals were killed on day 28 post-
stroke for further analysis.
Immunohistochemistry
Animals were i.p. injected with chloralhydrate (420 mg/kg
body weight) and transcardiacally perfused with 4% PFA at
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removed, post-ﬁxed in PFA and embedded in parafﬁn, and
coronal sections (2 lm) were prepared. Sections were
deparafﬁnized, boiled in 0.2% citrate buffer and incubated
with blocking solution (0.3% Triton X-100; 10% normal
goat serum in PBS; 1 h, RT). For analysis of BrdU
? or
Ki-67
? cells, sections were exposed to blocking solution
and subsequently stained with a rat monoclonal anti-BrdU
antibody (1:50; 18 h, 4C; Serotec, Germany), or a rabbit
monoclonal anti-Ki-67 antibody (1:100; 18 h, 4C; Abcam,
UK) and a goat anti-rat Alexa 594 (1:500, 1 h; Molecular
Probes, Germany), or a donkey anti-rabbit Alexa Fluor 568
(1:400, 1 h; Molecular Probes, Germany) secondary anti-
body. For differentiation analysis of BrdU
? cells, sections
were incubated with a mouse monoclonal anti-BrdU anti-
body (1:500; Roche, Germany), a goat polyclonal anti-
doublecortin antibody (1:50; Santa Cruz Biotechnology,
Germany), a rat polyclonal anti-GFAP antibody (1:500;
Zymed, Germany) or a rat biotin-conjugated anti-IB4
antibody (1:100; Vector, UK) for 18 h at 4C. For double
staining against BrdU and NeuN or CNPase, a rat mono-
clonal anti-BrdU antibody (see above) and a mouse
monoclonal anti-NeuN antibody (1:200, 18 h, 4C;
Chemicon, UK) or a mouse monoclonal anti-CNPase
antibody (1:400; Chemicon, Germany) were used. After
washing, sections were incubated for 1 h at RT with the
following secondary antibodies: goat anti-mouse Cy-3
(1:400; Dianova, Hamburg, Germany) or goat anti-rat
Alexa 594 (1:400; Dianova, Hamburg, Germany) for BrdU
staining, goat anti-rat Alexa 488 (1:250; Molecular Probes)
or donkey anti-goat Alexa 488 (1:250; Molecular Probes)
for GFAP or doublecortin (Dcx) staining, goat anti-mouse
Cy-3 (1:100; Jackson Immuno-Research, UK) for CNPase
staining and goat anti-mouse Alexa 488 (Molecular Probes,
Germany) for NeuN (1:400) staining.
TUNEL staining was performed incubating sections
with proteinase K (7 min, 37C), followed by exposure
to the TdT enzyme reaction according to the manufac-
turer’s manual (Roche, Germany). After several washing
steps and exposure to TUNEL blocking solution (20 min,
RT), sections were stained with a streptavidin-Alexa594-
conjugated secondary antibody (2 h, RT; Molecular
Probes).
Quantitative analysis of post-stroke cell injury, cell
proliferation and differentiation
Infarct volume analysis was performed on days 4, 14 and
28. Brains were removed and cut into four 2-mm slices.
Slices were stained with 2,3,5-triphenyltetrazolium chlo-
ride (TTC, 2%), and computer-based analysis of infarct
volumes was done using the software Image J as previously
described [12]. Assessment of post-ischemic edema
formation was performed as the increase of ipsilateral
hemispheric volume in comparison to the contralateral
hemisphere as described by Wacker et al. [41].
Quantitative analyses for immunohistochemical stain-
ings were performed, deﬁning regions of interest (ROIs)
within the SVZ and the basal ganglia (BG). Stereotactic
coordinates for quantitative analysis in the SVZ were
0.14 mm anterior, 2–3 mm ventral and 1–1.25 mm lateral
from bregma. Cell count analysis within the BG was done
at 0.14 mm anterior, 2.5–3.25 mm ventral and
1.5–2.25 mm lateral from bregma. Three sections per
animal and ROI were used. Cell death (TUNEL) and
neuronal density (NeuN) were assessed within ischemic
BG. The number of proliferating cells (BrdU and Ki-67)
was determined within the BG and the SVZ. Analysis of
cell differentiation was performed using the different
markers stated above with subsequent re-calculation as
percentages of BrdU
? cells. For assessment of general
post-ischemic neuronal differentiation, total numbers of
Dcx
? cells and NeuN
?/BrdU
? cells within the ischemic
BG are given. Data on cell proliferation and differentiation
reﬂect total numbers of counted cells within the SVZ and
the BG.
Visualization of anastomotic lines between the anterior
cerebral artery (ACA) and the middle cerebral artery
territory
In order to exclude increased brain injury of ephrin-B3
-/-
mice due to differences in macroscopic vessel anatomy,
vessel visualization was done following a modiﬁed pro-
tocol as described previously by us [42]. Non-ischemic
ephrin-B3
?/? and ephrin-B3
-/- mice were anaesthetized
with 1% isoﬂurane and injected with a lethal dose of
papaverine hydrochloride (50 mg/kg BW) intracardially to
ensure maximal vasodilatation and vascular ﬁlling fol-
lowed by infusion of 2 ml saline. The thoracic aorta was
clipped and the ascending aorta was cannulated. Carbon
black solution was prepared with two commercially
available inks, i.e., 1.8 ml of Scribtol (Pelikan, Germany)
and 0.2 ml of Stempelfarbe (Herlitz, Germany). Five
minutes after injection of papavarine, 2 ml of saline was
injected into the left ventricle, and immediately after-
wards 2 ml of carbon black solution was injected with
slight pressure over 40–50 s. After 10 min, animals were
decapitated and brains were removed. Photographs of the
dorsal and ventral brain surfaces were taken immediately
after removal of the brain. Anastomotic lines between
ACA and MCA territories were localized by tracing
peripheral branches to the points at which vessels were
connected. The distance from the midline to the line of
anastomosis of the left hemisphere was measured in
coronal planes at bregma and at ?1 mm from bregma.
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were always induced.
Analysis of post-stroke functional deﬁcits
Functional deﬁcits in motor coordination were assessed
using both the rota rod and the tightrope test. One day
before induction of stroke, all animals were trained before
the beginning of the actual tests on days 7, 14, 21 and 28
post-stroke. The rota rod test was performed using an
accelerating treadmill for mice (TSE Systems, Germany;
3 cm diameter). Mice were placed on the rotating drum
with an accelerating speed of 4–40 rpm. Maximum speed
was achieved after 260 s, and maximum testing time was
300 s. The time until animals dropped was registered and
statistically analyzed. Using the tightrope test, animals
were placed on a 60-cm-long tightrope grasping the string
with their forepaws according to a modiﬁed protocol from
Gerlai et al. [17]. All animals were tested twice per time
point. Maximum test time was 60 s, and results were
scored from 0 (minimum) to 20 (maximum) according to a
validated score (Table 1) depending on the time animals
spent on the rope and whether or not they reached the
platform.
Caspase-3 assays
Caspase-3 activity was determined using the ﬂuorophore
substrate Ac-DEVD-AMC (Biomol, Germany) in brain
homogenates of ischemic hemispheres at 1, 2, 3 and 4 h
after stroke. Whereas control animals received i.v. injec-
tions of 100 ll of 0.2% dimethyl sulfoxide (DMSO), others
received 100 ll of the caspase-3 inhibitor z-DEVD.fmk
(Biomol, Germany; 500 ng, solved in 0.2% DMSO) at the
beginning of the reperfusion. Left hemispheres were
complemented with lysis buffer containing 25 mmol/l
HEPES, pH 7.5, 1 mM EDTA, 10 mM 1,4-dithiothreitol
(Roche, Germany), 0.1% 3-[(3-cholamidopropyl)dimeth-
ylammonio]-1-propanesulfonate (CHAPS; Sigma-Aldrich,
Germany), 10% sucrose, 0.1% Triton X-100 with 10 lg/ml
of pepstatin A, aprotinin and leupeptin plus 1 mM phen-
ylmethylsulfonyl ﬂuoride (PMSF; all Sigma-Aldrich,
Germany). Samples were homogenized and centrifuged,
and supernatants were used for measurements applying
90 ll of samples and 10 ll of substrate (50 lM). Fluo-
rescence (355–460 nm) was detected at 2-min intervals for
20 min with a linear increase between 4–16 min. Caspase-
3 activity was re-calculated from the slope (ﬂuorescence
units per time) and is given as picomoles of substrate
cleaved per milligram of protein per minute based on a
standard curve for 7-amino-4-methylcoumarin (AMC;
Biomol, Germany). Protein concentration in the superna-
tant was determined using the Bradford assay.
For analysis of caspase-3-mediated effects on post-
ischemic injury, animals received 100 ll of z-DEVD.fmk
(500 ng, solved in 0.2% DMSO) or 100 ll of 0.2% DMSO
via femoral vein injections at the beginning of the reperfu-
sion. Moreover, animals received additional z-DEVD.fmk
or DMSO application via tail vein injection on days 1–3
post-stroke. Thereafter, animals were killed on day 4 and
infarct volumes were analyzed.
Detection of phosphorylated STAT1 and STAT3
Phosphorylated STAT1 and STAT3 were measured in
brain lysates of ischemic hemispheres at 24 h after stroke
using Western blot analysis. Generation of brain lysates
and Western blotting procedure were performed as
described above. Animals either received z-DEVD.fmk or
0.2% DMSO (see above) at the beginning of the reperfu-
sion. The following primary antibodies were used: rabbit
anti-phospho-STAT1 (1:2,000) and rabbit anti-phospho-
STAT3 (1:2,500; both obtained from Millipore, Germany).
Thereafter, membranes were incubated with a peroxidase-
coupled, goat anti-rabbit secondary antibody (1:2,000;
Abcam, UK), washed several times, immersed in ECL
solution and exposed to ECL-Hyperﬁlm (Amersham,
Germany).
Table 1 Assessment of tight rope test performance
Score Time (s) Platform arrival
20 1–6 ?
19 7–12 ?
18 13–18 ?
17 19–24 ?
16 25–30 ?
15 31–36 ?
14 37–42 ?
13 43–48 ?
12 49–54 ?
11 55–60 ?
10 55–60 -
9 49–54 -
8 43–48 -
7 37–42 -
6 31–36 -
5 25–30 -
4 19–24 -
3 13–18 -
2 7–12 -
1 1–6 -
00 -
Tightrope test results were assessed according to both time on the
rope (in seconds) and platform arrival (‘‘?’’ for arrival and ‘‘-’’ for
non-arrival). The scores ranged from 0 (minimum) to 20 (maximum)
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All data are given as mean ? standard deviation. For
comparison between two groups, the two-sided Student’s
t test was used. For analysis of score data from the tight-
rope test, however, the non-parametric Wilcoxon-Mann
Whitney test was used. A p value of\0.05 was considered
to be statistically signiﬁcant.
Results
In vitro characterization of SVZ-derived NPCs
from ephrin-B3
–/– mice
NPCs from both mouse strains were ﬁrst characterized in
vitro regarding neurosphere formation, cell proliferation
and differentiation as well as behavior after oxygen-glu-
cose deprivation (OGD). Ephrin-B3
-/--derived NPCs
showed signiﬁcantly enhanced primary neurosphere for-
mation and cell proliferation rates compared to controls
(Fig. 1a–f). Analysis of cell differentiation in serum con-
taining cell culture medium revealed an increased
expression of the neural stem cell/neural progenitor cell
marker nestin, the astroglial marker GFAP and the
neuronal marker beta-tubulin III in NPCs derived from
ephrin-B3
-/- mice (Fig. 1g, h). Importantly, protein
abundance between primary NPCs (P0) and NPCs from
cell culture passage 3 (P3) did not differ within each mouse
strain.
To exclude a higher sensitivity of ephrin-B3
-/--derived
NPCs to hypoxic-hypoglycemic injury, which is relevant
for the functional meaning of post-stroke neurogenesis in
vivo, NPCs were exposed to a 45-min OGD and subse-
quently re-cultivated at standard cell culture conditions
(Fig. 1i). OGD induced prominent cell injury in NPCs
derived from both mouse strains after 24 h of re-cultivation
under standard cell culture conditions. However, we
observed no signiﬁcant difference between cell injury of
NPCs that were derived from either ephrin-B3
-/- or eph-
rin-B3
?/? mice.
Analysis of cell proliferation and differentiation
after cerebral ischemia
We analyzed post-ischemic cell proliferation in ephrin-
B3
?/? and ephrin-B3
-/- mice using Ki-67 staining and
BrdU staining for up to 4 weeks post-stroke followed by a
differentiation analysis of BrdU
? cells. Staining against
Ki-67, a marker for current cell proliferation, revealed a
Fig. 1 In vitro characterization of ephrin-B3
-/--derived NPCs.
Neurosphere-forming neural precursor cells (NPCs) were derived
from subventricular zones (SVZ) of ephrin-B3
?/? (a) and ephrin-
B3
-/- (b) mice. Primary neurospheres were counted 7 days after cell
culture (c). Cell proliferation rates were assessed by staining of
neurospheres with anti-phospho-histone H3 (d–f). Cell differentiation
was analyzed using Western blotting (g) against nestin, GFAP,
CNPase and beta-tubulin III in primary neurospheres (P0) and
neurospheres from passage 3 (P3). Data (h) are presented as relative
protein expression referred to actin expression. i NPCs were exposed
to 45 min of oxygen-glucose deprivation (OGD) and re-cultivated for
24 h at standard cell culture conditions followed by subsequent
analysis of cell injury. Controls were incubated under standard cell
culture conditions only without OGD. Scale bars 100 lm. *Signif-
icantly different from ephrin-B3
?/? mice, p\0.05
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123signiﬁcantly higher number of Ki-67
? cells within the
ischemic hemisphere of ephrin-B3
-/- mice, albeit cell
numbers from both mouse strains gradually declined over
time (Fig. 2a). In line with this, high numbers of BrdU
?
cells were found in the SVZ and the ischemic striatum from
both experimental groups, with the vast majority of cells
located in the striatum (Fig. 2b–d). Although the number of
BrdU
? cells gradually declined over time in both groups,
cell numbers were always higher in ephrin-B3
-/- mice. No
BrdU
? cells were found in the contralateral striatum (data
not shown). On the contrary, BrdU
? cells were signiﬁ-
cantly higher within the contralateral SVZ in ephrin-B3
-/-
mice at any time point analyzed. We observed, for
instance, 7.5 ± 2.4 BrdU
? cells/mm
2 in ephrin-B3
?/? and
17.0 ± 3.5 BrdU
? cells/mm
2 in ephrin-B3
-/- mice on
day 28.
Differentiation analysis of proliferating cells was
determined using immunohistochemical labeling of neu-
ronal, astroglial and oligodendroglial proteins (Fig. 2e–j).
Since BrdU staining at subacute time points essentially
reﬂects activated microglia [11], initial IB4 staining was
performed on day 4 post-stroke, revealing 96.4 ± 1.4% in
ephrin-B3
-/- versus 96.7 ± 3.9% of co-localizations in
ephrin-B3
?/? mice in the ischemic striatum. No co-local-
ization of BrdU
? cells with the oligodendroglial marker
CNPase was found at any time point analyzed (data not
shown). On the contrary, GFAP expression, which was
very low on day 4 (data not shown), gradually increased
Fig. 2 Analysis of post-ischemic cell proliferation and differentia-
tion. Cell proliferation in ephrin-B3
?/? and ephrin-B3
-/- mice was
analyzed using Ki-67 (a) and BrdU (b) staining. BrdU
? cells were
scattered within the ischemic striatum as exemplarily depicted on day
28 for ephrin-B3
?/? (c) and ephrin-B3
-/- mice (d). Differentiation
analysis of BrdU
? cells performed at the time points given referred to
induction of stroke (e). Stainings were performed against GFAP (f–g),
Dcx (h, i) and NeuN (j). Quantitative analyses were performed in
both the subventricular zone (SVZ) and the ischemic striatum
followed by calculation of total cell numbers. Data are given as
percentages of co-localizations of BrdU and the speciﬁc marker
referred to total numbers of BrdU
? cells. Arrows indicate co-
localization. Scale bar 40 lm. *Signiﬁcantly different from ephrin-
B3
?/? mice, p\0.05
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123over time in both experimental groups, showing a signiﬁ-
cantly higher number of BrdU
?/GFAP
? cells from
2 weeks on in ephrin-B3
-/- mice. Distribution analysis of
BrdU
?/GFAP
? cells in ephrin-B3
?/? mice revealed
39.6 ± 5.9% of cells located in the SVZ on day 14 and
22.1 ± 4.7% of cells residing in the SVZ on day 28. In
ephrin-B3
-/- mice, 36.1 ± 3.8% of BrdU
?/GFAP
? cells
were located in the SVZ on day 14, whereas on day 28 only
16.3 ± 5.2% of cells were found in the SVZ. Immature
neuronal differentiation, as assessed by Dcx staining on
day 4, was restricted to the SVZ and enhanced in ephrin-
B3
-/- mice, although the total amount of Dcx
?/BrdU
?
cells was very low (not shown). Over time, the number of
Dcx
?/BrdU
? cells, which were from day 14 on also present
in the ischemic striatum, gradually increased in both ani-
mal strains, but were always signiﬁcantly higher in ephrin-
B3
-/- mice. Distribution analysis of BrdU
?/Dcx
? cells in
ephrin-B3
?/? mice revealed 38.3 ± 7.3% of cells to be
found in the SVZ on day 14 and 29.7 ± 3.1% cells in the
SVZ on day 28. In ephrin-B3
-/- mice, 41.7 ± 7.3% of
Dcx
?/BrdU
? cells on day 14 and 30.6 ± 3.8% of cells on
day 28 were found in the SVZ. Co-localization of BrdU
?
cells with the mature neuronal marker NeuN was only
observed on day 28 in ephrin-B3
-/- mice, where a few
newborn cells were seen in the ischemic striatum.
Post-ischemic neurogenesis is enhanced
in ephrin-B3
–/– mice
Since post-ischemic cell proliferation differed between
ephrin-B3
?/? and ephrin-B3
-/- mice (Fig. 2a, b), a post-
analysis of absolute numbers of Dcx
? and NeuN
?/BrdU
?
cells was performed, revealing signiﬁcantly increased
absolute numbers of Dcx
? cells in ephrin-B3
-/- mice
compared to ephrin-B3
?/? mice (Fig. 3a). Beyond day 4
post-stroke, Dcx
? cells were not only restricted to the SVZ
(Fig. 3b, c), but also formed typical chain-like clusters
within the ischemic striatum (Fig. 3d, e). In ephrin-B3
?/?
mice, 35.6 ± 5.4% of Dcx
? cells resided in the SVZ on
day 14 and 36.4 ± 6.3% of Dcx
? cells were found in the
SVZ on day 28. In ephrin-B3
-/- mice, 37.1 ± 7.2% of
Dcx
? cells were found in the SVZ on day 14 and
29.2 ± 4.8% of Dcx
? cells were observed in the SVZ on
day 28. Moreover, Dcx
? cells were signiﬁcantly increased
in the contralateral SVZ of ephrin-B3
-/- mice at any time
point analyzed, whereas no Dcx
? cells were found in the
contralateral striatum of either animal strain (data not
shown). Analysis of absolute numbers of NeuN
?/BrdU
?
cells at 4 weeks revealed a few scattered cells within the
lesion site of ephrin-B3
-/- mice but not within the SVZ
(Fig. 3f), whereas no NeuN
?/BrdU
? cells were detectable
Fig. 3 Post-ischemic
neurogenesis is increased in
ephrin-B3
-/- mice. Absolute
amounts of Dcx
? (a–e) and
NeuN
?/BrdU
? (f) cells were
determined in ephrin-B3
?/? and
ephrin-B3
-/- mice. In ephrin-
B3
-/- mice, Dcx
? cells were
signiﬁcantly increased (a)i n
both the subventricular zone
(SVZ, c) of the lateral ventricle
(LV) and in the ischemic
striatum (e). On the contrary,
Dcx
? cells in ephrin-B3
?/?
mice were reduced in both the
SVZ (b) and the striatum (d).
Images (b–e) represent data
from day 28 post-stroke,
whereas arrows indicate the
location of the SVZ. Likewise,
the number of NeuN
?/BrdU
?
cells was signiﬁcantly increased
in the ischemic striatum of
ephrin-B3
-/- mice 4 weeks
after stroke (f). Scale bar
40 lm. *Signiﬁcantly different
from ephrin-B3
?/? mice;
p\0.05
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123in ephrin-B3
?/? mice. These data suggest that endogenous
neurogenesis is increased in ephrin-B3
-/- mice after
induction of cerebral ischemia.
Post-ischemic brain injury is enhanced
in ephrin-B3
–/– mice
In order to verify whether or not increased neuronal
regeneration in ephrin-B3
-/- mice was associated with
higher resistance to cerebral ischemia, brain injury was
analyzed for up to 4 weeks. Surprisingly, ephrin-B3
-/-
mice revealed signiﬁcantly enhanced infarct volumes at
any time point analyzed (Fig. 4a–g), which was associated
with prominent ipsilateral edema formation (Fig. 4h), an
increased number of TUNEL
? cells (Fig. 4i–k) and
reduced neuronal density in these animals (Fig. 4l–n).
Increased post-stroke injury, however, was not due to
changes in LDF levels or impaired reperfusion between
ephrin-B3
-/- and ephrin-B3
?/? mice (data not shown).
Even more importantly, there was no signiﬁcant difference
in macroscopic cerebral vessel anatomy as analyzed by
visualization of anastomotic lines between the ACA and
the MCA territories (Fig. 4o–q) as well as by qualitative
analysis of the circle of Willis (Fig. 4r, s). Enhanced brain
injury in ephrin-B3
-/- mice also resulted in reduced
functional recovery with regard to motor coordination as
assessed by the rota rod and the tightrope test (Fig. 4t, u).
Noteworthily, despite the well-known loss of unilateral
movement control in ephrin-B3
-/- mice due to re-crossing
projections of corticospinal tracts with subsequent simul-
taneous movement of both hind legs [25], pre-ischemic test
performance did not differ between knockout and wild-
type mice (Fig. 4t, u).
Elevation of neurogenesis in ephrin-B3
-/- mice does
not exclusively correlate with the extent of brain injury
Since cerebral ischemia itself triggers neurogenesis, we
analyzed whether or not elevated neurogenesis in ephrin-
B3
-/- mice was due to enhanced ischemic injury in these
animals. Therefore, animals were exposed to either 20 min
(ephrin-B3
-/-) or 30 min of ischemia (ephrin-B3
?/?),
yielding no signiﬁcant difference in neuronal density
between the two groups (Fig. 5a). On the other hand,
analysis of post-ischemic neurogenesis still yielded sig-
niﬁcantly increased numbers of both Dcx
? and NeuN
?/
BrdU
? cells within the peri-infarct area of ephrin-B3
-/-
mice (Fig. 5b, c), which were in the same order as in
animals exposed to 30 min of ischemia (Fig. 3a, f).
In order to further support our hypothesis that ephrin-B3
deﬁciency is crucial for the aforementioned observations
made in ephrin-B3
-/- mice, knockout animals received
continuous intraventricular infusion of soluble ephrin-B3-
Fc via mini pumps for as long as 4 weeks. As expected,
effects on both brain injury and neurogenesis were
reversed by ephrin-B3-Fc-molecules, i.e., animals receiv-
ing ephrin-B3-Fc showed less prominent brain injury and
reduced post-ischemic neurogenesis than control mice
(Fig. 5d–f).
Aggravated ischemic injury in ephrin-B3
–/– mice
is associated with caspase-3-dependent phosphorylation
of STAT1
Since the absence of ephrin-B3 has been shown to induce
a caspase-3-mediated cell death under non-ischemic con-
ditions [16], we next analyzed whether or not caspase-3
plays a role in the aggravation of brain injury in ephrin-
B3
-/- mice. Caspase-3 activity showed a maximum at 2 h
post-stroke in both experimental groups, but was signiﬁ-
cantly higher in ephrinB3
-/- mice at this time point and
beyond (Fig. 6a). Systemic administration of the caspase-3
inhibitor z-DEVD.fmk resulted in almost completely
inhibited enzyme activity in both animal strains (Fig. 6a),
but yielded pronounced reduction of brain injury only in
ephrin-B3
-/- and not in ephrin-B3
?/? mice (Fig. 6b).
With consideration of Eph/ephrin signaling having been
shown to involve activation of STAT proteins [26], which
are thought to have numerous and in part opposing effects
in the pathogenesis of stroke [34, 35, 46], protein abun-
dance of phosphorylated STAT1 and STAT3 was analyzed
after induction of stroke (Fig. 6c, d). Phosphorylation
levels of STAT3 did not differ between the two animal
groups at 24 h post-stroke, and treatment with
z-DEVD.fmk did not affect protein abundance. On the
contrary, protein abundance of phosphorylated STAT1
was signiﬁcantly increased in ephrin-B3
-/- mice as
compared to controls. Furthermore, systemic application
of the caspase-3 inhibitor yielded signiﬁcant reduction of
STAT1 phosphorylation in ephrin-B3
-/- mice, but did not
affect STAT1 phosphorylation in wild-type animals. These
data suggest that aggravated ischemic brain injury in
ephrin-B3
-/- mice is associated with a caspase-3-depen-
dent phosphorylation of STAT1.
Discussion
In the present study, we analyzed post-ischemic neuro-
genesis and cell proliferation, brain injury and functional
neurological outcome in ephrin-B3
?/? and ephrin-B3
-/-
mice. Our study shows that post-stroke neurogenesis is
enhanced in ephrin-B3
-/- mice without contributing to
functional neurological recovery. Rather, brain injury in
these animals is signiﬁcantly enhanced, involving a cas-
pase-3 associated phosphorylation of STAT1.
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the SVZ, and both the surrounding tissue and Eph/ephrin
interactions in these regions have been shown to affect
proliferation and apoptosis [8, 20, 24, 32]. The role of eph-
rin-B3 in adult neurogenesis and neurosphere formation has
been described under physiological conditions [32].
However, as neurosphere formation and neurogenesis
depend on the species and the age of the animal [4, 5, 40],
these results cannot be transferred to our experimental par-
adigm, which included older animals. In line with Ricard
et al. [32] showing an increased self-renewal capacity of
NPCs isolated from ephrin-B3
-/- mice, we found enhanced
Fig. 4 Ischemic brain injury is aggravated in ephrin-B3
-/- mice.
Infarct volume analysis was performed using TTC staining (a–g) with
typical examples of infarct volumes at the time points given for
ephrin-B3
?/? (a, c, e) and ephrin-B3
-/- mice (b, d, f). Ipsilateral
edema formation (h) is given as relative increase of ipsilateral
hemisphere volume as compared to the contralateral non-ischemic
hemisphere. Immunohistochemical analysis of brain injury was
assessed using TUNEL staining (i–k) and NeuN staining (‘‘neuronal
density’’, l–n). Macroscopic analysis of vessel anatomy (o–s) in non-
ischemic ephrin-B3
-/- (p, r) and ephrin-B3
?/? (q, s) mice after
intrathoracic injection of carbon black solution. The distance from the
midline of the anastomotic line between the anterior cerebral artery
(ACA) and the middle cerebral artery (MCA) vascular territory was
determined at the level of bregma and at ?1 mm from bregma (o–q).
Anastomotic lines between the left ACA and MCA territories were
determined by tracing peripheral branches on dorsal brain surfaces to
the points at which vessels were connected (p–q; indicated by dotted
lines). Post-stroke motor coordination deﬁcits were assessed in
ephrin-B3
-/- and ephrin-B3
?/? mice using the rota rod (t) and the
tightrope test (u) at the time points given. Scale bar 1 mm.
*Signiﬁcantly different from ephrin-B3
?/? mice, p\0.05
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123neurosphere formation and cell proliferation rates of NPCs
derived fromephrin-B3
-/-mice,which wasassociatedwith
signiﬁcantly increased astroglial and neuronal differentia-
tion rates. Noteworthily, cell differentiation rates were
independent of cell passage states, i.e., there was no differ-
ence between primary NPCs and NPCs from passage 3.
Although the SVZ itself is not affected by focal cerebral
ischemia [12], we further analyzed whether or not NPCs
from both mouse strains show different resistance rates
against OGD. Importantly, no signiﬁcant difference was
observed, which might be due to the fact that ephrin-B3 is
not expressed in the SVZ itself but in the surrounding
tissue, which seems to only indirectly affect proliferation
and differentiation of NPCs [32].
Cerebral ischemia stimulates endogenous cell prolifer-
ation and neurogenesis [2, 21]. Accordingly, stroke-
induced high cell proliferation rates within the lesion site of
both animal strains. Cell proliferation in the ischemic
hemisphere as well as in the contralateral non-ischemic
SVZ, however, was always higher in ephrin-B3
-/- than in
ephrin-B3
?/? mice, suggesting that basal cell proliferation
within the germinal niche of ephrin-B3
-/- mice is
enhanced, as has been previously shown under physiolog-
ical conditions [32].
A differentiation analysis of proliferating cells revealed
a high IB4 abundance of these cells on day 4, reﬂecting
rather activation of microglia than cell differentiation of
BrdU
? cells. The decline of cell proliferation over time in
both experimental groups therefore most likely reﬂects a
decreased inﬂammatory response in the ischemic tissue,
which is in line with our previous observations where
subacute post-stroke cell proliferation was due to microglia
activation and not due to enhanced neurogenesis [11].
Astroglial differentiation analysis of proliferating cells
revealed an increase over time in both ephrin-B3
?/? and
ephrin-B3
-/- mice, but were found to be higher in the
knockout group from day 14 on. Immature neuronal dif-
ferentiation of BrdU
? proliferating cells increased over
time in both experimental groups, which is consistent with
previous reports, where stroke has been shown to increase
neuronal differentiation of BrdU
? cells [2, 3, 12, 48].
Nevertheless, immature neuronal differentiation of prolif-
erating cells was always higher in ephrin-B3
-/- mice. In
spite of this, no newborn mature neurons in the ischemic
Fig. 5 Enhanced post-ischemic neurogenesis in ephrin-B3
-/- mice
does not exclusively correlate to the extent of brain injury. All data a–
f refer to day 28 post-stroke. a–c Animals were exposed to 20 min
(ephrin-B3
-/-) or 30 min (ephrin-B3
?/?) of cerebral ischemia
followed by NeuN staining for assessment of ‘‘neuronal density’’
(a). Post-ischemic neurogenesis was assessed analyzing total absolute
amounts of Dcx
? (b) and NeuN
?/BrdU
? (c) cells in both animal
strains. d–f Analysis of ‘‘neuronal density’’ (d) and numbers of Dcx
?
(e) as well as NeuN
?/BrdU
? (f) cells in ephrin-B3
-/- mice that
received intraventricular infusion for 28 days of either ephrin-B3-Fc
or Fc-fragments as control. *Signiﬁcantly different from ephrin-B3
?/?
or ephrin-B3
-/- control mice, p\0.05
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123hemisphere in ephrin-B3
?/? mice were observed, whereas
only a few scattered NeuN
?/BrdU
? cells were found in
ephrin-B3
-/- mice 4 weeks post-stroke. In line with this,
absolute amounts of newborn neuronal cells, which are
more relevant for neuroregeneration, were also signiﬁ-
cantly increased in ephrin-B3
-/- mice. The low neuronal
differentiation rates observed in ephrin-B3
-/- mice might,
however, also be in part due to the limited observation
period of 4 weeks with a maximum age of newborn cells of
20 days due to the BrdU-labeling protocol. Although
increased neuronal differentiation of BrdU
? cells in ephrin-
B3
-/- mice has been described before under physiological
conditions [32], this is the ﬁrst time where increased neu-
ronal differentiation in these animals was observed under
ischemic conditions. Similarly, enhanced proliferation of
SVZ-derived NPCs has recently been described after
induction of traumatic brain injury (TBI) in ephrin-B3
-/-
mice via a p53-dependent pathway [38]. Since stroke and
TBI share pathophysiological aspects, including inﬂam-
mation, further studies have to address the question
whether or not p53 is also involved in enhanced prolifer-
ation of SVZ-derived NPCs after cerebral ischemia in
ephrin-B3
-/- mice.
As post-stroke neurogenesis was signiﬁcantly increased
in ephrin-B3
-/- mice, we further analyzed whether or not
this phenomenon was associated with enhanced resistance
to stroke and improved post-stroke recovery. Surprisingly,
knockout animals suffered from extensive ischemic brain
injury, which was neither due to impaired blood ﬂow nor to
differences in vessel anatomy, ultimately resulting in
impaired functional recovery of ephrin-B3
-/- mice. In this
context, the aforementioned enhanced numbers of GFAP
?/
BrdU
? cells in ephrin-B3
-/- animals might rather reﬂect
astroglial proliferation during scar formation than genuine
astroglial differentiation of SVZ-derived BrdU
? cells.
As stroke triggers neurogenesis [39], we analyzed
whether the enhanced neurogenesis observed in ephrin-
B3
-/- mice might be due to mere increased brain injury in
these animals. Reduction of thread occlusion time in
knockout animals resulting in similar infarct sizes com-
pared to wild-type animals did not, however, affect
neurogenesis in ephrin-B3
-/- mice. Not only was post-
ischemic neurogenesis increased when compared to wild-
type animals, but was also as high as in ephrin-B3
-/- mice
that were exposed to longer times of MCA occlusion.
In this context, proof of principle experiments using
continuous intraventricular infusion of soluble ephrin-B3-
Fc-molecules in ephrin-B3
-/- mice reversed the afore-
mentioned observations, i.e., both brain injury and
neurogenesis were decreased in these animals. As such,
Fig. 6 Aggravated injury in ephrin-B3
-/- mice is associated with
caspase-3-dependent phosphorylation of STAT1. a Caspase-3 activity
was determined between 1–4 h after induction of stroke in ephrin-
B3
?/? (black symbols) and ephrin-B3
-/- (open symbols) mice that
were given i.v. injections of either 0.2% DMSO as control or the
caspase-3 inhibitor z-DEVD.fmk at the beginning of the reperfusion.
b TTC staining on day 4 post-stroke in animals that had received
systemic application of either z-DEVD.fmk or DMSO on days 0–3.
c Detection of phosphorylated STAT1 and STAT3 in ipsilateral
hemispheres at 24 h after stroke using Western blotting with
subsequent densitometric analysis (d) referred to actin abundance.
*Signiﬁcantly different from ephrin-B3
?/? mice, p\0.05
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123enhanced post-ischemic endogenous neurogenesis in eph-
rin-B3
-/- mice does not exclusively depend on the extent
of ischemic injury, but is also in part a consequence of
intrinsic properties within the knockout mouse.
Although the role of apoptosis and activation of caspase-
3 in cerebral ischemia have been studied before, precise
apoptotic pathways and demonstration of clinical beneﬁts
are still elusive [6, 10, 28]. Interestingly, activation of
caspase-3 recently has been shown to occur in the absence
of ephrin-B3, resulting in apoptotic cell death under non-
ischemic conditions [16]. In the present study, determina-
tion of post-stroke caspase-3 activity revealed a signiﬁcant
increase in ephrin-B3
-/- mice when compared to controls.
Although systemic application of the caspase-3 inhibitor
z-DEVD.fmk signiﬁcantly reduced caspase-3 activity in
both animal strains, infarct volumes were only decreased in
ephrin-B3
-/- but not in ephrin-B3
?/? mice. Noteworthily,
ephrin-B3
?/? and ephrin-B3
-/- mice developed similar
infarct volumes after treatment with the caspase-3 inhibi-
tor. Therefore, caspase-3 activation might be one critical
pathway involved in the aggravation of stroke injury in
ephrin-B3
-/- mice.
As STAT proteins are mediators of Eph/ephrin signaling
[26], the abundance of phosphorylated STAT1 and STAT3
was analyzed, resulting in enhanced STAT1 abundance in
ephrin-B3
-/- mice 24 h post-stroke. On the contrary, no
difference in phosphorylated STAT3 abundance between
knockout and wild-type animals was observed. Interest-
ingly, systemic application of the caspase-3 inhibitor
yielded signiﬁcantly reduced abundance of phosphorylated
STAT1 in ephrin-B3
-/- mice, suggesting that a caspase-3-
dependent activation of STAT1 might be involved in the
aggravation of brain injury in ephrin-B3
-/- mice. Never-
theless, the role of STAT proteins in cerebral ischemia and
other pathological conditions is still elusive and in part
contradictory. STAT proteins are important intracellular
mediators of cytokines, among which STAT3 is generally
thought rather to induce neuroprotection than cell death
[22, 30]. On the contrary, activation of STAT1 has been
described to induce both cell injury and neuroprotection
under different pathological conditions [18]. We here
describe a caspase-3-dependent phosphorylation of STAT1
under ischemic conditions for the ﬁrst time. In order to
verify whether or not aggravation of ischemic injury in
ephrin-B3
-/- mice is solely dependent on caspase-3-
mediated activation of STAT1, further studies are required.
However, this beyond the scope of the present work.
In conclusion, our study demonstrates that post-ischemic
endogenous neurogenesis is increased in ephrin-B3
-/-
mice. Ephrin-B3 deﬁciency, however, also leads to
increased brain injury and subsequent impaired neurolog-
ical recovery, which is associated with a post-ischemic
caspase-3-mediated activation of STAT1, pointing towards
the notion that cell proliferation, neurogenesis and neuro-
logical recovery do not necessarily go in line with each
other after stroke. Nevertheless, enhanced proliferation and
neuronal differentiation rates of ephrin-B3
-/- derived
NPCs might be one interesting tool for overcoming the
limitations of cell-based therapies in cerebral ischemia,
such as poor survival and low differentiation rates of
transplanted cells.
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